rough HealthCheckUSA
(http://www.HealthCheckUSA.com). The test targets a potential U.S. market
of over 60 million individuals and a potential global market exceeding 200
million individuals who take aspirin for prevention.

Unlike functional platelet tests, which require freshly drawn blood
that must be evaluated within at least four hours, the AspirinWorks Test
only requires a urine sample that can be obtained in any doctor's office or
patient service center, making the test convenient for both physician and
patient.

Corgenix is a leader in the development and manufacturing of
specialized diagnostic kits for immunology disorders, vascular diseases and
bone and joint disorders, including the world's only non-blood-based test
for aspirin effect. Corgenix diagnostic products are commercialized for use
in clinical laboratories throughout the world. The company currently sells
over 50 diagnostic products through a global distribution network and has
significant experience advancing products through the FDA process. More
information is available at http://www.corgenix.com.

Statements in this press release that are not strictly historical facts
are "forward looking" statements (identified by the words "believe",
"estimate", "project", "expect" or similar expressions) within the meaning
of the Private Securities Litigation Reform Act of 1995. These statements
inherently involve risks and uncertainties that could cause actual results
to differ materially from the forward-looking statements. Factors that
would caus'/>"/>

(Date:3/3/2015)... NEW YORK , March 3, 2015 ... that Jeffrey I.D. Lewis has joined the ... Practice, resident in the New York ... also handles trademark matters, as well as other intellectual ... registered patent attorney, Mr. Lewis represents both plaintiffs and ...

... Escalon Medical Corp.,(Nasdaq: ESMC ) today announced ... March 31, 2008., For the third quarter of ... $6,900,000 reported in the same period last fiscal,year. Product ... the,Company,s business units., Net revenue for the third ...

(Date:2/13/2015)... TAIPEI , Feb. 13, 2015 ... service company that aims to transform cancer genomic ... announced that the company has raised US$ 8 million ... Based in Taipei, Taiwan ... tests, ACTDrug™, ACTOnco™. With the aim to implement ...

... It,s long been known that alcohol use in ... birth defects, but researchers who study fetal alcohol syndrome ... disorder, detecting it early, or effectively treating it, say ... the issue of Developmental Neuroscience , four first-year ...

... How do we begin to understand what early life was ... planet shifted from an oxygen-free and probably ice-covered realm to ... who decodes the early record of life on Earth has ... a significantly clearer picture of this dynamic environment. Alison Olcott ...

... , THE WOODLANDS, Texas , June 15 ... company focused on discovering breakthrough treatments for human disease, announced today ... clinical trial of LX4211 for patients with type 2 ... June 19 – 22, 2010 in San Diego, ...

... hormones which belong to the transforming ... superfamily is a large group of ... aspects of development, reproductive function and ... TGF-s, bone morphogenetic proteins, growth differentiation ...

The new Silencer siRNA Starter Kit is perfect for researchers new to RNAi. It provides all of the reagents, protocols, and instructions necessary to get underway with siRNA transfection and ensure su...

... laboratories working in a regulated environment, ... pipette calibration software that automates gravimetric ... a framework that meets todays regulatory ... a secure solution that includes a ...